Trends of phosphorus levels after intravenous administration of ferric carboxymaltose

被引:0
|
作者
Borrellas, A. [1 ]
Domingo, M. [1 ]
Lupon, J. [1 ]
Pulido, A. [1 ]
Gonzalez, B. [1 ]
Rivas, C. [1 ]
Velayos, P. [1 ]
Bares, D. [1 ]
Diaz, V. [1 ]
Crespo, E. [1 ]
Martinez, S. [1 ]
Codina, P. [1 ]
Santiago-Vacas, E. [1 ]
Cediel, G. [1 ]
Bayes-Genis, A. [1 ]
机构
[1] Germans Trias & Pujol Univ Hosp, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [31] A Systematic Literature Review and MetaAnalysis of the Incidence of Serious or Severe Hypersensitivity Reactions after Administration of Ferric Derisomaltose and Ferric Carboxymaltose
    Biggar, Patrick
    Kennedy, Nicholas
    Poehlmann, Johannes
    Pollock-Wilkins, Richard F.
    BLOOD, 2021, 138
  • [32] Incidence of postpartum depression after treatment of postpartum anaemia with intravenous ferric carboxymaltose, intravenous ferric derisomaltose or oral ferrous sulphate: A randomized clinical trial
    Tavcar, Lea Bombac
    Hrobat, Hana
    Gornik, Lea
    Velikonja, Vislava Globevnik
    Lucovnik, Miha
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY-X, 2023, 20
  • [33] Danger of co-administration ferric carboxymaltose and denosumab: hypophosphatemia
    Seker, Aysun
    Durmus, Nurdan Senturk
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2025, 37 (01):
  • [34] Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia
    Bailie, George R.
    Mason, Nancy A.
    Valaoras, Thomas G.
    HEMODIALYSIS INTERNATIONAL, 2010, 14 (01) : 47 - 54
  • [35] The new generation of intravenous iron: chemistry, pharmacology, and toxicology of ferric carboxymaltose
    Funk, Felix
    Ryle, Peter
    Canclini, Camillo
    Neiser, Susann
    Geisser, Peter
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2010, 60 (6A): : 345 - 353
  • [36] Hypophosphatemia related to intravenous iron therapy with ferric carboxymaltose: A case series
    Seng, Nigel Wei-Peng
    Barco, Jason Bae
    Wong, Marc Hai-Liang
    Lim, Kai-Xiong
    Peh, Wee-Ming
    Ng, Choong-Tatt
    Cushway, Tim
    Foo, Fung-Joon
    Koh, Frederick Hong-Xiang
    TRANSFUSION MEDICINE, 2023, 33 (06) : 503 - 508
  • [37] Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia: Letter to Editor
    Kanshaiym, Sakiyeva
    Zhurabekova, Gulmira
    Abdelazim, Ibrahim A.
    Starchenko, Tatyana
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2020, 42 (01) : 98 - 99
  • [38] Intravenous ferric carboxymaltose is effective and safe in patients with inflammatory rheumatic diseases
    Salvadori, Ugo
    Vittadello, Fabio
    Al-Khaffaf, Ahmad
    Maier, Armin
    Cappelletto, Paola C.
    Daves, Massimo
    Raffeiner, Bernd
    BLOOD TRANSFUSION, 2020, 18 (03) : 176 - 181
  • [39] Treating postpartum anemia with intravenous ferric carboxymaltose in a randomized controlled study
    Seid, Melvin H.
    Rogers, Ralph
    Dinh, Quinn
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (06) : S26 - S26
  • [40] Hypophosphatemia Associated with Intravenous Ferric Carboxymaltose Complicated by Multiple Insufficiency Fractures
    Turin, Christie
    Hvisdas, Christopher
    Khan, Amna
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 108 - 109